Xylo-Acino 0.05 %
Xylo-Acino 0.05 % is a medicine authorised by Swissmedic under authorisation number 62745. The authorisation holder is Acino Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 30 July 2012 and the authorisation is valid without a time limit. ATC code R01AA07 places the medicine in the group Nasal preparations.
| Authorisation number | 62745 |
|---|---|
| Name | Xylo-Acino 0.05 % |
| Full name | Xylo-Acino 0.05 %, Nasenspray |
| Authorisation holder | Acino Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R01AA07 |
| First authorisation | 30 July 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xylo-Acino 0.05 %, Nasenspray | D | 30 July 2012 |
| 2 | Xylo-Acino 0.1 %, Nasenspray | D | 30 July 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 10 | ml | R01AA07 | 12.02.1. | D |
| 3 | 10 | ml | R01AA07 | 12.02.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xylo-Acino 0.05 % authorised in Switzerland?
Yes. Xylo-Acino 0.05 % is authorised by Swissmedic under authorisation number 62745, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xylo-Acino 0.05 % have?
Xylo-Acino 0.05 % is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Xylo-Acino 0.05 %?
The authorisation holder is Acino Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.